rolipram has been researched along with Bronchiolitis, Exudative in 1 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "In rolipram-treated animals, the epithelium was completely disturbed until Day 14." | 1.31 | Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts. ( Funk, RH; Kasper, M; Ploetze, K; Roth-Eichhorn, S; Schade, I; Schueler, S; Wunderlich, J, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roth-Eichhorn, S | 1 |
| Schade, I | 1 |
| Kasper, M | 1 |
| Ploetze, K | 1 |
| Wunderlich, J | 1 |
| Funk, RH | 1 |
| Schueler, S | 1 |
1 other study available for rolipram and Bronchiolitis, Exudative
| Article | Year |
|---|---|
Anti-proliferative properties of the phosphodiesterase-4 inhibitor rolipram can supplement immunosuppressive effects of cyclosporine for treatment of obliterative bronchiolitis in heterotopic rat allografts.
Topics: Animals; Bronchiolitis Obliterans; Cyclosporine; Epithelial Cells; Immunosuppressive Agents; Male; P | 2001 |